# Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)

> **NCT04222374** · — · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 200 (actual)

## Conditions studied

- Kidney Cancer

## Interventions

- **PROCEDURE:** Intervention in the UroCCR sites
- **PROCEDURE:** Intervention in the CRB of Bordeaux University Hospital
- **PROCEDURE:** Intervention at the Methodology and Data Management Centre of Bordeaux University Hospital
- **PROCEDURE:** Subsequent intervention at the NCI (for information)

## Key facts

- **NCT ID:** NCT04222374
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222374, "Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04222374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*